Tuis4502 • TYO
add
Takeda Pharmaceutical Co Ltd
Vorige sluiting
¥4 132,00
Dagwisseling
¥4 087,00 - ¥4 135,00
Jaarwisseling
¥3 852,00 - ¥4 494,00
Markkapitalisasie
6,52 bn JPY
Gemiddelde volume
3,89 m
P/V-verhouding
22,50
Dividend-opbrengs
4,69%
Primêre beurs
TYO
Marknuus
Barron's
17 uur gelede
This ETF Has Returned 40% in 2024. Why It Can Beat the S&P 500 Again Next
Year.
0,18%
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (JPY) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 1,18 bn | 12,75% |
Bedryfskoste | 540,19 mjd | -10,33% |
Netto inkomste | 92,05 mjd | 291,64% |
Netto winsgrens | 7,83 | 270,22% |
Wins per aandeel | — | — |
EBITDA | 433,99 mjd | 55,12% |
Effektiewe belastingkoers | 22,84% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (JPY) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 859,02 mjd | 170,09% |
Totale bates | 14,57 bn | -2,01% |
Totale aanspreeklikheid | 7,65 bn | -1,92% |
Totale ekwiteit | 6,92 bn | — |
Uitstaande aandele | 1,59 mjd | — |
Prys om te bespreek | 0,95 | — |
Opbrengs op bates | 3,92% | — |
Opbrengs op kapitaal | 4,57% | — |
Kontantvloei
Netto kontantverandering
| (JPY) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 92,05 mjd | 291,64% |
Kontant van bedrywe | 280,96 mjd | 41,25% |
Kontant van beleggings | -75,13 mjd | -24,02% |
Kontant van finansiering | -110,04 mjd | 21,76% |
Netto kontantverandering | 54,00 mjd | 3 129,84% |
Beskikbare kontantvloei | 97,22 mjd | -39,87% |
Meer oor
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. Wikipedia
Gestig
12 Jun. 1781
Webwerf
Werknemers
49 281
